SCHEMBL19979421

SCHEMBL19979421

c1ccc(-n2c3ccccc3c3c4ccccc4c(-c4ccc5c(c4)c4ccccc4n5-c4nc(-c5cccc6ccccc56)c5ccccc5n4)cc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
ATM Q13315 1/20 0.35
FLT3 P36888 3/20 0.34
BMX P51813 2/20 0.34
PTGER4 P35408 1/20 0.33
MAPT P10636 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PTGES O14684 1/20 0.32
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
TUBB4A P04350 1/20 0.30
TUBB P07437 1/20 0.30
TUBA3C P0DPH7 1/20 0.30
TUBA1B P68363 1/20 0.30
TUBA4A P68366 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17408743 1.00 KDM4E (0.35) KDM4EL3MBTL1ATMFLT3BMX
SCHEMBL19979440 0.94 KDM4E (0.35) KDM4EL3MBTL1ATMFLT3BMX
SCHEMBL17408710 0.94 KDM4E (0.35) KDM4EL3MBTL1ATMFLT3BMX
SCHEMBL17408510 0.94 KDM4E (0.35) KDM4EL3MBTL1ATMFLT3BMX
SCHEMBL19979425 0.94 KDM4E (0.35) KDM4EL3MBTL1ATMFLT3BMX
SCHEMBL14232993 0.92 L3MBTL1 (0.35) KDM4EL3MBTL1ATMFLT3BMX
SCHEMBL18232166 0.91 L3MBTL1 (0.36) KDM4EL3MBTL1ATMPTGER4MAPT
SCHEMBL17408493 0.91 L3MBTL1 (0.39) KDM4EL3MBTL1ATMPTGER4MAPT
SCHEMBL17408454 0.91 L3MBTL1 (0.39) KDM4EL3MBTL1ATMPTGER4MAPT
SCHEMBL16475764 0.91 L3MBTL1 (0.41) KDM4EL3MBTL1ATMFLT3BMX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10763443-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD (KR) 2020-09-01 US disclosed
US-10672992-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD (KR) 2020-06-02 US disclosed
US-20190173023-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-06-06 US disclosed
US-20180083204-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-03-22 US disclosed
US-20180083204-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190173023-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ESR1 KDM4E 365/4885L3MBTL1 658/4885ATM 2714/4885
US-10763443-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof NFE2L2, OR51E2, ESR1 KDM4E 365/4885L3MBTL1 658/4885ATM 2714/4885
US-20180083204-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ESR1 KDM4E 365/4885L3MBTL1 658/4885ATM 2714/4885
US-10672992-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof NFE2L2, OR51E2, ESR1 KDM4E 365/4885L3MBTL1 658/4885ATM 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.